|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratoire de Physiologie, Université Libre de Bruxelles, Brussels, Belgium (V.S., A.G., F.M., S.S.-S.); and Service de Réanimation Polyvalente, Hôpitaux Sud, Marseille, France (A.R.)
Received December 5, 2005; accepted January 6, 2006
| Abstract |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Cell Culture. A549 and H441 cells were grown in culture flasks in RPMI 1640 media (Invitrogen, Merelbeke, Belgium) adjusted to contain 4.5 g/l glucose and supplemented with 1% penicillin/streptomycin, 5% fetal bovine serum (Greiner-Bio-One, Wemmel, Belgium) and 10 nM dexamethasone. Upon reaching confluence, cells were removed from the flask with trypsin-EDTA and subcultured at a 1:5 ratio. For the experiments, cells were plated onto glass coverslips (diameter, 15 mm; Menzel, VWR, Leuven, Belgium) at 50% confluence. The media were changed every other day. Cells were used between days 2 and 5 after plating.
Patch-Clamp Experiments. Nystatin-perforated whole-cell patch-clamp experiments were conducted as described previously (Shlyonsky et al., 2005
). Coverslips with cell monolayers were placed in a chamber on an inverted microscope and perfused at a rate of 0.3 ml/min with bathing media containing 140 mM NaCl, 4 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, and 15 mM glucose, pH 7.3 adjusted with NaOH (final sodium concentration, 144 mM). The perfusion system consisted of glass syringes connected to an eightway manifold, which permitted testing up to eight experimental conditions on the same cell. The dead volume of the perfusion system was 30 µl, allowing complete exchange of medium in the patch area in 10 to 15 s. In low sodium bathing media, 134 mM NaCl was replaced with 134 mM N-methyl-D-glucamine, pH 7.3 adjusted with HCl (final chlorine concentration, 135 mM). For whole-cell measurements, the pipette solution contained 10 mM NaCl, 10 mM KCl, 130 mM potassium gluconate, 10 mM HEPES, and 15 mM glucose, pH 7.2 adjusted with KOH (final potassium concentration, 144 mM). The osmolarity of the solutions was 290 to 300 mOsM. Stock solution of nystatin (40 mg/ml in DMSO) was prepared immediately before the experiment. The patch pipettes were double-step pulled from borosilicate glass capillaries (Hilgenberg, Malsfeld, Germany) using a vertical puller (PB-7; Narishige, Tokyo, Japan). The pipette tips were first filled with nystatin-free pipette solution and back-filled with the same solution containing nystatin (400 µg/ml). Filled pipettes had resistances of 2 to 4 M
. Membrane currents were measured at room temperature (20-22°C) with a PC501A amplifier (Warner Instruments, Hamden, CT) at a filter bandwidth of 500 Hz (4-pole Bessel) and recorded online using a PCI-6025E interface (National Instruments, Austin, TX) and WinWCP software (J. Dempster, Stratchdale University, Stratchdale, UK) at a sampling rate of 1 kHz. The same software was used for the record analysis. After achieving high-resistance seals (>1 G
) between the cell surface and the glass pipettes, liquid junction potential compensation was balanced according to the conventional procedure (Barry and Lynch, 1991
). Liquid-junction potentials were calculated using Microsoft Excel macros based on the generalized Henderson equation (Barry and Lynch, 1991
). Whole-cell patch-clamp configuration induced by nystatin permeabilization was achieved within 15 to 20 min at room temperature. This perforated patch configuration prevents cell dialysis of high molecular weight substances and keeps intracellular Ca2+ ion concentration intact. In all experiments, 70% compensation of series resistance (Rs) was used. The mean cell capacitances of the cells used in the study were 31.4 ± 0.9 pF in A549 cells and 38.2 ± 2.2 pF in H441 cells. Whole-cell patches were perfused with bathing solution containing 1 mM heptanol. Cells were used within 60 min after being taken from the incubator. The holding potential was -50 mV. Voltage ramp protocols consisted of a -100 mV step followed by a ramp ranging from -100 to +100 mV over 1 s. Ramps were applied every 14 s. The voltage wave modified by the Rs compensation circuit was recorded simultaneously. Stability of the patches was assessed by evaluating Rs (<30 M
) at the beginning and the end of each experiment, and a change greater than 10% in Rs during the course of the experiment led to disregard of the record from the analysis. In single-channel experiments, pipette solution was normal bath medium, and inside-out patches were excised into a medium containing 10 mM NaCl, 10 mM KCl, 130 mM potassium gluconate, 10 mM HEPES, 15 mM glucose, 2.5 mM EGTA, and 1 mM CaCl2, pH 7.2 adjusted with NaOH ([Ca]free = 100 nM, calculated using CaBuf software; G. Droogmans, Katholieke Universiteit Leuven, Leuven, Belgium). In high-calcium medium ([Ca]free = 1 µM), total CaCl2 concentration was 2.15 mM, and in nominally calciumfree medium ([Ca]free = 1 nM), CaCl2 was omitted. According to convention, outward potassium channel currents (cell to pipette) were represented as upward transitions in single-channel records. Single-channel records were analyzed using pCLAMP software (Molecular Devices, Sunnyvale, CA). The single-channel amplitudes and Po were determined from all event lists of single-channel records as described previously (Mies et al., 2004
). In some cases, because of complex activity of different channel types, single-channel amplitudes were measured by the cursors on the computer screen. NPo, the product of the number of channels in a patch (N) by the open probability, which reflects channel activity within a patch, was calculated using the equation
, where T is the total recording time, i is the number of open channels, ti is the recording time during which i channels were open, and N is the apparent number of channels within the patch determined as the highest observable level (in our experiments at 1 µM free Ca2+). Therefore, NPo can be calculated without making any assumption about the total number of channels in a patch or the open probability of single channels. All NPo values were calculated for the last 30 s of 2-min periods of recording preceding the change in the chamber bath. Only the patches that showed complete cessation of channel activity upon lowering of free Ca2+ concentration to 1 nM were analyzed for NPo values.
Preparation of Solutions Containing Halogenated Gases. Gas mixtures containing halothane (Fluothane; Zeneca, Destelbergen, Germany), isoflurane (Forene; Abbott Laboratories Ltd, Queen-borough, Kent, UK), or sevoflurane (Sevorane; Abbott Laboratories) were prepared by passing medical air (Air Liquide, Paris, France) through a calibrated vaporizer (for halothane, Halothane vaporizer, Mie, Vickers Medical company, Exeter, UK; for isoflurane, Isotec 3, Ohmeda, Steeton UK; for sevoflurane, Sigme Elie, Penlon Limited, Abingdon, UK). The settings on the vaporizers were as follows: halothane, 1, 2, or 4% atm; isoflurane, 1.8, 3.6, or 5% atm; and sevoflurane, 2.8, 5.6, or 8% atm. An anesthetic gas analyzer (Capnomac; Datex, Helsinky, Finland) was used to monitor continuously the concentrations of volatile anesthetics in the gas phase. The gas mixture was passed through the bath solution at a flow of 100 ml/min using a 30-ml glass syringe equipped with a glass frit and connected through a cap to a bag allowing equilibration of concentrations between gas and liquid phases. After at least 20 min of gassing, the solution was perfused in the bath chamber through tubing made of gas-impermeable polytetrafluoroethylene. Perfusion of whole-cell patches with the medium gassed in the same way but without halothane had no effect on the currents (n = 3, data not shown).
Measurement of Halogenated Gas Concentration in the Bath Solution. Anesthetics were quantified by ultraviolet absorption using extraction of dissolved gas by hexane (Blanck and Thompson, 1980
). Analysis was performed on a Genesys 10UV spectrophotometer (Thermospectronic, Rochester, NY). Stock solutions of liquid gases (8.67 mol/l for halothane, 7.96 mol/l for isoflurane, and 7.46 mol/l for sevoflurane) were diluted in saline to construct calibration curves. At 22°C, 1, 2, and 4% atm halothane in the gas phase yielded solution concentrations of 0.90, 1.87, and 3.02 mM; 1.8, 3.6, and 5% atm isoflurane in the gas phase yielded 0.71, 1.73, and 2.49 mM concentrations; and 2.8, 5.6, and 8% atm sevoflurane yielded 1.22, 2.51, and 3.95 mM concentrations, respectively. However, in the presence of synthetic surfactant in saline (5.1 mg/ml phospholipids and 0.1 mg/ml protein), 2% atm halothane yielded a 2.46 mM concentration.
Statistical Analysis. Data are expressed as mean ± S.E.M. Changes in current densities were compared using the paired twotailed t test. One-way analysis of variance on ranks followed by Dunn's post hoc test was used to determine the concentration-dependent effects. In all comparisons, p
0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
The increase in inward currents and the decrease in outward currents by halothane were concentration-dependent, as shown in Fig. 2. Isoflurane and sevoflurane had significant effects only at higher concentrations. Isoflurane (5%, 2.49 mM) activated inward current by 32.3 ± 6.8% (p < 0.05 versus no gas, Dunn's test) and inhibited outward currents by 17.0 ± 3.3% (p < 0.05 versus no gas, Dunn's test, n = 8), whereas 8% sevoflurane (3.95 mM) activated inward current by 39.9 ± 6.6% (p < 0.05 versus no gas, Dunn's test) and inhibited outward currents by 26.3 ± 4.9% (p < 0.05 versus no gas, Dunn's test, n = 8).
|
Amiloride inhibited more than 60% of the current at -90 mV in control conditions with a reversal potential of +68.5 ± 2.4 mV, indicating the presence of highly selective Na+ channels (ENaC). After 2 min of exposure to 4% halothane, amiloride-sensitive inward currents increased by 84 ± 22% (n = 15, Fig. 3, A and B,
) with no change in reversal potential (+69.5 ± 2.8 mV). Perfusion of whole-cell patches with amiloride prevented 90 ± 7% of the increase in inward currents but not the inhibition of outward currents (Fig. 3B,
). The I/V curves in the presence of both halothane and amiloride were the same independently of the sequence in which these agents were added. These results are consistent with a specific activation of ENaCs by halothane.
|
quinidine (200 µM)
quinacrine (100 µM) >> glibenclamide (20 µM) > 4-aminopyridine (2 mM)
barium (1 mM). Niflumic acid (200 µM), an inhibitor of Cl- channels, did not influence significantly whole-cell currents (n = 5, data not shown). This pharmacological profile is consistent with a predominance of K(Ca). After 2 min of exposure to 4% halothane, TEA-sensitive outward currents decreased by 63 ± 7% (n = 10, Fig. 3, C and D,
). Furthermore, perfusion of cells with TEA obliterated 90 ± 9% of halothane inhibition of outward currents without effect on inward currents (Fig. 3D,
), indicating specific inhibition of K+ channels.
Mechanisms of Action of Halothane on Ion Channels
The cPLA2 Pathway. Cytosolic phospholipase A2 (cPLA2) regulates the function of ion transporters, and its activity is sensitive to halothane (Denson et al., 1996
, 2005
; Worrell et al., 2001
; Carattino et al., 2003
). We conducted experiments using aristolochic acid (200 µM), an inhibitor of cPLA2 (n = 7, Fig. 4A). As expected, aristolochic acid significantly increased inward currents and decreased outward currents, consistent with the basal activity of cPLA2 in A549 cells. However, the effects of aristolochic acid and halothane were additive for both types of currents (Fig. 4A), indicating that the action of halothane on ENaC and K+ channels in A549 cells is not through an inhibition of cPLA2.
|
). In contrast, trypsin application did not prevent the effect of halothane on K+ currents (Fig. 4B,
).
The Calcium Gating Mechanism. It was suggested that halogenated gases interfere with the Ca2+ gating of K(Ca) channels, leading to their inhibition, as shown in bovine chromaffin cells (Pancrazio et al., 1993
). We tested this hypothesis on single channels in excised inside-out patches of A549 cells. A total of 23 patches were obtained, of which 3 were empty (13%). Seven patches presented complex activity of different channel types. Three types of channels reversing at voltages lower than -70 mV were observed. Small-conductance calcium-sensitive channels with current amplitudes of 0.45 ± 0.05 pA at +50 mV were observed in 11 patches (48%), large-conductance calcium-sensitive channels with current amplitudes of 7.14 ± 0.43 pA at +50 mV were observed in four patches (17%), and medium-conductance calcium-insensitive spontaneously activating/deactivating channels with current amplitudes of 1.13 ± 0.21 pA at +50 mV were observed in 11 patches (48%). The first two groups of channels ceased completely their activity at a free calcium concentration of 1 nM, confirming their identity as SK(Ca) and BK(Ca) potassium channels. The small-conductance calcium-sensitive channels were equally inhibited by halothane at low and high free Ca2+ concentrations. NPo decreased by 95.5% from 0.25 ± 0.20 to 0.01 ± 0.01 at 100 nM Ca2+ and by 95.2% from 0.83 ± 0.59 to 0.04 ± 0.03 at 1 µMCa2+ (Fig. 5, A and C, n = 3). In contrast, large-conductance calcium-sensitive channels were insensitive to halothane at both free Ca2+ concentrations (Fig. 5B). These channels were merely silent at basal free Ca2+ concentrations (100 nM) and were activated more than a 1000-fold at 1 µM Ca2+ (Fig. 5B, third and fourth traces). Thus, we did not observe any interference of halothane with the Ca2+ gating mechanism of K(Ca) channels.
|
| Discussion |
|---|
|
|
|---|
In our experiments, we used millimolar concentrations of volatile anesthetic gases. We are aware that clinically relevant halothane concentrations are <1 mM (Franks and Lieb, 1996
). However, these submillimolar concentrations of halothane are measured in blood, whereas halothane concentration in the alveolar lining liquid during volatile anesthesia is unknown. In contrast to blood, the alveolar liquid contains highly hydrophobic surfactant. According to the oil/gas partition coefficient for halothane of 225, high molar concentrations of halothane are expected. Indeed, in the presence of phospholipids from synthetic surfactant, we measured halothane concentrations that were 30% higher than in the absence of surfactant (see Materials and Methods). In our epithelial cell culture model, we also observed complete reversibility of the effect of halothane even at the highest dose and after 30 min of exposure, which indicates the lack of acute toxicity of halothane on cell cultures. Finally, although we did not observe significant effects on inward and outward currents using low doses of halothane (<1 mM), the doseresponse curve showed saturation.
| Mechanism of ENaC Activation by Halothane |
|---|
|
|
|---|
Na+ Self-Inhibition. Self-inhibition is a regulatory mechanism of Na+ transport that refers to fast inactivation of ENaCs when extracellular Na+ concentration is increased (Chraibi and Horisberger, 2002
). The nature of the extracellular Na+ concentration sensor is still unidentified, but inhibition is inactivated by trypsin, leading to increased apical Na+ transport (Chraibi and Horisbeger, 2002
). Our experiments with either trypsin administration or low Na+ medium show that these two conditions, which block self-inhibition, completely mask the effect of halothane. The lack of stimulation of ENaCs by halothane in the presence of trypsin and in the low Na+ medium suggests that halothane may release ENaC self-inhibition, thus increasing channel open probability. Because the amount of ENaC current is directly proportional to the open probability, the number of functional channels, and their current amplitude, it is likely that halothane does not modify either single-channel conductance or selectivity.
The release of ENaC self-inhibition by halothane, leading to the increase in ENaC open probability, could result from a physical interaction of these gases with membrane lipids, which in turn could affect channel protein conformation. Halothane is known to influence membrane lipid bilayer fluidity through reorientation of the lipid tails (Hauet et al., 2003
) and has been recently shown to increase the segmental order of the lipids close to the membrane surface in membrane simulation models (Pickholz et al., 2005
). Halothane, which distributes at the liquid-aqueous interface of cell membranes, can partition into amphiphilic membrane domains, thereby potentially changing the behavior of transport proteins (Tang and Xu, 2002
). Because ENaC activity decreases with decreasing lipid ordering (Awayda et al., 2004
) and is stimulated by cooling, which increases lipid order (Chraibi and Horisberger, 2002
), halogenated gases may, at least partly, change ENaC protein conformation through an increase in segmental order leading to an increase ENaC activity. Although never investigated, a direct interaction of halogenated gases with ENaC proteins cannot be ruled out.
Mechanisms of K+ Channel Inhibition by Halothane. Various types of K+ channels have been described in alveolar cells, including voltage-gated (Kv), inwardly rectifying, and K(Ca) channels (DeCoursey et al., 1988
; Peers et al., 1990
; Koong et al., 1993
; Szkotak et al., 2001
; O'Grady and Lee, 2003
). In A549 cells, large- and small-conductance K(Ca) channels have been characterized (Ridge et al., 1997
; Karle et al., 2004
), and Kv1.2, Kv1.5, and Kv2.1 have been identified by polymerase chain reaction measurements (Perez-Garcia and Lopez-Lopez, 2000
). In the present study, whole-cell outward currents were largely inhibited by TEA and quinidine, consistent with a predominance of K(Ca) channels. Their identity was confirmed at the single-channel level according to conductance and calcium sensitivity. Our results of an inhibition of these channels by halothane are similar to those reported in bovine adrenal chromaffin cells (Pancrazio et al., 1993
) and in oocytes (Hashiguchi-Ikeda et al., 2003
). Two mechanisms have been suggested to explain the inhibition of K(Ca) channels by halogenated gases. The first is through inhibition of cPLA2, which results in the decrease of arachidonic acid release, an important molecule for K(Ca) channel gating (Denson et al., 2005
). We ruled out this mechanism in alveolar cells because the inhibition of cPLA2 by aristolochic acid decreased K+ currents but did not prevent potassium channel inhibition by halothane. Second, halogenated gases interfere with the Ca2+ gating of K(Ca) channels (Pancrazio et al., 1993
). At the single-channel level, we have identified two types of calcium-sensitive potassium channels, namely SK(Ca) and BK(Ca) channels. In contrast to chromaffin cells, BK(Ca) channels in A549 cells were insensitive to halothane, whereas the inhibition of SK(Ca) channels was not affected by cytoplasmic Ca2+ concentration, suggesting that halothane does not interfere with the Ca2+ gating mechanism. These results indicate that K(Ca) channels from different families are differentially affected by volatile anesthetics in alveolar cells, as was observed with cloned channels expressed in oocytes (Namba et al., 2000
).
Effect of Halogenated Gases on Transepithelial Na+ Transport. Stimulation of sodium current with trypsin indicates that in cultured alveolar cells, basal sodium entry represents only a fraction of its maximal capacity. Whether this transport rate is found in vivo is not clear. Indeed, there are some regulatory mechanisms in vivo that are likely to decrease ENaC self-inhibition, such as the channel-activation proteases, which are abundantly expressed and secreted by type II pneumocytes and act similarly to trypsin (Planes et al., 2005
). Our experiments suggest that the activation of sodium entry by proteases in vivo may modify the degree of ENaC activation by halothane, which in turn will reflect in transepithelial Na+ transport changes. Studies on frog skins mounted in Ussing chambers have shown transient activation of short-circuit current by halothane (Szulc and Knapowski, 1975
). In contrast, Molliex et al. (1998
) have reported that exposure of primary cultures of rat type II pneumocytes to halothane leads to a concomitant decrease in amiloride-sensitive 22Na uptake and of Na+-K+-ATPase activity. However, these effects could result from a decrease in protein expression or trafficking, because all assays in that study were designed with halothane preincubation alone. Inhibition of K+ channels by halothane could impair both Na+ entry and Na+-K+-ATPase activity. Indeed, K+ channels are involved in alveolar fluid absorption (O'Grady and Lee, 2003
), and inhibition of KATP channels decreases amiloride-sensitive Na+ currents in freshly isolated rat alveolar cells (Leroy et al., 2004
). However, from our results, it seems that any decrease in Na+ absorption caused by K+ channel inhibition will be masked by the large and sustained ENaC activation by halothane, but because the maximal activation of ENaC after 10 min of exposure to halothane progressively decreases with time (Fig. 1C), we cannot rule out that the decrease in K+ exit alters Na+ transport at long times of exposure to halothane (>30 min).
In summary, our experiments show a marked activation of ENaC by halothane through a release of self-inhibition and an inhibition of small-conductance calcium-sensitive K+ channels in human alveolar cells independent of cPLA2 activity and Ca2+ gating. These ion movements are not accompanied by changes in cell capacitance. The absence of cell swelling indicates that basolateral exit of both sodium and potassium is not impaired. It is therefore likely that shorttime exposure (<30 min) to halothane should not modify significantly ion and fluid transport across the alveolar epithelium.
| Acknowledgements |
|---|
| Footnotes |
|---|
This work was funded by grants from Université Libre de Bruxelles and Fonds Defay. V.S. is the recipient of a European Respiratory Society Fellowship (number 306). A.G. is a Fonds National de la Recherche Scientifique doctoral fellow.
ABBREVIATIONS: ENaC, epithelial sodium channel; TEA, tetraethylamonium, cPLA2, cytosolic phospholipase A2; K(Ca), Ca2+-activated K+ channel; SK(Ca), small-conductance Ca2+-activated K+ channel; BK(Ca), large-conductance Ca2+-activated K+ channel; DMSO, dimethyl sulfoxide; Rs, series resistance; NPo, the product of the number of channels in a patch by the open probability; Kv, voltage-gated potassium channel.
Address correspondence to: Dr. S. Sariban-Sohraby, Laboratoire de Physiologie et Physiopathologie, Campus Erasme CP 604, 808, route de Lennik, 1070 Bruxelles, Belgium. E-mail: sohraby{at}ulb.ac.be
| References |
|---|
|
|
|---|
Barry PH and Lynch JW (1991) Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 121: 101-117.[CrossRef][Medline]
Blanck TJ and Thompson M (1980) Measurement of halothane by ultraviolet spectroscopy. Anesth Analg 59: 481-483.
Carattino MD, Hill WG, and Kleyman TR (2003) Arachidonic acid regulates surface expression of epithelial sodium channels. J Biol Chem 278: 36202-36213.
Chen X, Yamakage M, and Namiki A (2002) Inhibitory effects of volatile anesthetics on K+ and Cl- channel currents in porcine tracheal and bronchial smooth muscle. Anesthesiology 96: 458-466.[CrossRef][Medline]
Chraibi A and Horisberger JD (2002) Na self inhibition of human epithelial Na channel: temperature dependence and effect of extracellular proteases. J Gen Physiol 120: 133-145.
DeCoursey TE, Jacobs ER, and Silver MR (1988) Potassium currents in rat type II alveolar epithelial cells. J Physiol 395: 487-505.
Denson DD, Li J, Wang X, and Eaton DC (2005) Activation of BK channels in GH3 cells by a c-PLA2-dependent G-protein signaling pathway. J Neurophysiol 93: 3146-3156.
Denson DD, Worrell RT, and Eaton DC (1996) A possible role for phospholipase A2 in the action of general anesthetics. Am J Physiol 270: C636-C644.[Medline]
Franks NP and Honore E (2004) The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol Sci 25: 601-608.[CrossRef][Medline]
Franks NP and Lieb WR (1994) Molecular and cellular mechanisms of general anaesthesia. Nature (Lond) 367: 607-614.[CrossRef][Medline]
Franks NP and Lieb WR (1996) Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiology 84: 716-720.[CrossRef][Medline]
Hartness ME, Lewis A, Searle GJ, O'Kelly I, Peers C, and Kemp PJ (2001) Combined antisense and pharmacological approaches implicate hTASK as an airway O2 sensing K+ channel. J Biol Chem 276: 26499-26508.
Hashiguchi-Ikeda M, Namba T, Ishii TM, Hisano T, and Fukuda K (2003) Halothane inhibits an intermediate conductance Ca2+ -activated K+ channel by acting at the extracellular side of the ionic pore. Anesthesiology 99: 1340-1345.[CrossRef][Medline]
Hauet N, Artzner F, Boucher F, Grabielle-Madelmont C, Cloutier I, Keller G, Lesieur P, Durand D, and Paternostre M (2003) Interaction between artificial membranes and enflurane, a general volatile anesthetic: DPPC-enflurane interaction. Biophys J 84: 3123-3137.[Medline]
Huneke R, Fassl J, Rossaint R, and Luckhoff A (2004) Effects of volatile anesthetics on cardiac ion channels. Acta Anaesthesiol Scand 48: 547-561.[CrossRef][Medline]
Juvin P, Clerici C, Loiseau A, Mantz J, Aubier M, Friedlander G, and Desmonts JM (1999) Halothane stimulates a Na+ H+ antiporter involved in the regulation of intracellular pH in alveolar epithelial cells. Anesth Analg 89: 480-483.
Karle C, Gehrig T, Wodopia R, Hoschele S, Kreye VA, Katus HA, Bartsch P, and Mairbaurl H (2004) Hypoxia-induced inhibition of whole cell membrane currents and ion transport of A549 cells. Am J Physiol 286: L1154-L1160.
Koong AC, Giaccia AJ, Hahn GM, and Saad AH (1993) Activation of potassium channels by hypoxia and reoxygenation in the human lung adenocarcinoma cell line A549. J Cell Physiol 156: 341-347.[CrossRef][Medline]
Leroy C, Dagenais A, Berthiaume Y, and Brochiero E (2004) Molecular identity and function in transepithelial transport of KATP channels in alveolar epithelial cells. Am J Physiol 286: L1027-L1037.
Matthay MA, Folkesson HG, and Verkman AS (1996) Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 270: L487-L503.
Mies F, Shlyonsky V, Goolaerts A, and Sariban-Sohraby S (2004) Modulation of epithelial Na+ channel activity by long-chain n-3 fatty acids. Am J Physiol 287: F850-F855.
Molliex S, Dureuil B, Aubier M, Friedlander G, Desmonts JM, and Clerici C (1998) Halothane decreases Na,K-ATPase and Na channel activity in alveolar type II cells. Anesthesiology 88: 1606-1613.[Medline]
Namba T, Ishii TM, Ikeda M, Hisano T, Itoh T, Hirota K, Adelman JP, and Fukuda K (2000) Inhibition of the human intermediate conductance Ca2+-activated K+ channel, hIK1, by volatile anesthetics. Eur J Pharmacol 395: 95-101.[CrossRef][Medline]
Nielsen VG, Baird MS, Geary BT, and Matalon S (2000) Halothane does not decrease amiloride-sensitive alveolar fluid clearance in rabbits. Anesth Analg 90: 1445-1449.
O'Grady SM and Lee SY (2003) Chloride and potassium channel function in alveolar epithelial cells. Am J Physiol 284: L689-L700.
Pancrazio JJ, Park WK, Lynch C 3rd (1993) Inhalational anesthetic actions on voltage-gated ion currents of bovine adrenal chromaffin cells. Mol Pharmacol 43: 783-794.[Abstract]
Patel AJ, Honore E, Lesage F, Fink M, Romey G, and Lazdunski M (1999) Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci 2: 422-426.[CrossRef][Medline]
Peers C, Kemp PJ, Boyd CA, and Nye PC (1990) Whole-cell K+ currents in type II pneumocytes freshly isolated from rat lung: pharmacological evidence for two subpopulations of cells. Biochim Biophys Acta 1052: 113-118.[Medline]
Perez-Garcia MT and Lopez-Lopez JR (2000) Are Kv channels the essence of O2 sensing? Circ Res 86: 490-491.
Pickholz M, Saiz L, and Klein ML (2005) Concentration effects of volatile anesthetics on the properties of model membranes: a coarse-grain approach. Biophys J 88: 1524-1534.[CrossRef][Medline]
Planes C, Leyvraz C, Uchida T, Angelova MA, Vuagniaux G, Hummler E, Matthay M, Clerici C, and Rossier B (2005) In vitro and in vivo regulation of transepithelial lung alveolar sodium transport by serine proteases. Am J Physiol 288: L1099-L1109.
Rezaiguia-Delclaux S, Jayr C, Luo DF, Saidi NE, Meignan M, and Duvaldestin P (1998) Halothane and isoflurane decrease alveolar epithelial fluid clearance in rats. Anesthesiology 88: 751-760.[CrossRef][Medline]
Ridge FP, Duszyk M, and French AS (1997) A large conductance, Ca2+ -activated K+ channel in a human lung epithelial cell line (A549). Biochim Biophys Acta 1327: 249-258.[Medline]
Shlyonsky V, Goolaerts A, Van Beneden R, and Sariban-Sohraby S (2005) Differentiation of epithelial Na+ channel function. An in vitro model. J Biol Chem 280: 24181-24187.
Szkotak AJ, Ng AM, Sawicka J, Baldwin SA, Man SF, Cass CE, Young JD, and Duszyk M (2001) Regulation of K+ current in human airway epithelial cells by exogenous and autocrine adenosine. Am J Physiol 281: C1991-C2002.
Szulc R and Knapowski J (1975) The effect of halothane on active transport of sodium in the epithelial cell. Anaesth Resusc Intensive Ther 3: 279-283.[Medline]
Takala RS, Soukka HR, Kirvela OA, Kujari HP, Pelliniemi LJ, Kaapa PO, and Aantaa RE (2002) Alveolar integrity and ultrastructure in pigs remain undamaged after exposure to sevoflurane. Acta Anaesthesiol Scand 46: 1137-1143.[CrossRef][Medline]
Tang P and Xu Y (2002) Large-scale molecular dynamics simulations of general anesthetic effects on the ion channel in the fully hydrated membrane: the implication of molecular mechanisms of general anesthesia. Proc Natl Acad Sci USA 99: 16035-16040.
Worrell RT, Bao HF, Denson DD, and Eaton DC (2001) Contrasting effects of cPLA2 on epithelial Na+ transport. Am J Physiol 281: C147-C156.
This article has been cited by other articles:
![]() |
V. Shlyonsky, A. Goolaerts, F. Mies, and R. Naeije Electrophysiological Characterization of Rat Type II Pneumocytes in Situ Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||